HALEON PLC
LSE:HLN

Watchlist Manager
HALEON PLC Logo
HALEON PLC
LSE:HLN
Watchlist
Price: 380.3 GBX 2.12% Market Closed
Market Cap: 34.4B GBX
Have any thoughts about
HALEON PLC?
Write Note

Operating Margin
HALEON PLC

18.9%
Current
21%
Average
5.5%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
18.9%
=
Operating Profit
2.1B
/
Revenue
11.2B

Operating Margin Across Competitors

Country UK
Market Cap 34.7B GBP
Operating Margin
19%
Country FR
Market Cap 176B EUR
Operating Margin
19%
Country UK
Market Cap 117.3B GBP
Operating Margin
18%
Country IN
Market Cap 5.7T INR
Operating Margin
22%
Country DE
Market Cap 27.7B EUR
Operating Margin
11%
Country US
Market Cap 25.1B USD
Operating Margin
10%
Country JP
Market Cap 2.9T JPY
Operating Margin
7%
Country IN
Market Cap 1.2T INR
Operating Margin
21%
Country IN
Market Cap 909.1B INR
Operating Margin
15%
Country US
Market Cap 10.2B USD
Operating Margin
19%
Country IN
Market Cap 741.3B INR
Operating Margin
31%
No Stocks Found

HALEON PLC
Glance View

Market Cap
34.7B GBX
Industry
Consumer products

Haleon PLC emerged as a significant player in the global consumer health market when it was spun off from GlaxoSmithKline in July 2022. As a standalone entity, Haleon focuses on delivering everyday health products that enhance personal well-being, relying on a portfolio brimming with trusted brands like Sensodyne, Panadol, and Voltaren. With an impressive presence in over 100 countries, the company capitalizes on the growing consumer shift towards preventative healthcare and wellness, offering a range of over-the-counter medications, oral health products, and vitamins. This strategic approach positions Haleon not only as a trusted name but also as a vital contributor to the ongoing trend of self-care, making it an intriguing option for long-term investors seeking growth in resilient sectors. As Haleon charts its path forward, the company emphasizes sustainable growth and innovation, seeking to resonate with health-conscious consumers amid an increasingly competitive landscape. By investing in research and development, Haleon aims to expand its product offerings and enhance its market position. The company's focus on operational efficiency, coupled with strategic partnerships and an agile supply chain, reflects its commitment to driving profitability and shareholder value. With a strong foundation rooted in consumer trust and a forward-looking vision, Haleon PLC stands ready to navigate the evolving health landscape, presenting an appealing narrative for investors drawn to enterprises poised for sustainable success.

HLN Intrinsic Value
336.95 GBX
Overvaluation 11%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
18.9%
=
Operating Profit
2.1B
/
Revenue
11.2B
What is the Operating Margin of HALEON PLC?

Based on HALEON PLC's most recent financial statements, the company has Operating Margin of 18.9%.